SEC Form D private-offering filing

Enveric Biosciences, Inc.

Name: Enveric Biosciences, Inc. - new SEC Form D private-offering filing, Cambridge, MA
Published: 2025-10-03

A new SEC Form D private-offering notice from Cambridge, MA, an undisclosed offering target in Biotech. The source filing is one click away.

Enveric Biosciences, Inc. site↗ Verified via SEC Form D

Clinical stage biotechnology company developing neuroplastogenic small molecule therapeutics for psychiatric and neurological disorders, traded on Nasdaq as ENVB.

Filed 2025-10-03Filed to raise UndisclosedFirst money in 2025-09-18HQ (as filed) Cambridge, MASector Biotech ✓Stage (inferred) IndeterminateCall status Needs classification

Source linked the Form D on EDGAR↗Website verified enveric.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.